JP2005501097A - 膨張可能な胃内滞留装置 - Google Patents
膨張可能な胃内滞留装置 Download PDFInfo
- Publication number
- JP2005501097A JP2005501097A JP2003520705A JP2003520705A JP2005501097A JP 2005501097 A JP2005501097 A JP 2005501097A JP 2003520705 A JP2003520705 A JP 2003520705A JP 2003520705 A JP2003520705 A JP 2003520705A JP 2005501097 A JP2005501097 A JP 2005501097A
- Authority
- JP
- Japan
- Prior art keywords
- retention device
- gastric retention
- drug
- gastric
- hydrochloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
- A61K49/0419—Microparticles, microbeads, microcapsules, microspheres, i.e. having a size or diameter higher or equal to 1 micrometer
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Jellies, Jams, And Syrups (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31307801P | 2001-08-16 | 2001-08-16 | |
PCT/US2001/046146 WO2003015745A1 (fr) | 2001-08-16 | 2001-10-22 | Dispositif de retention gastrique expansible |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2005501097A true JP2005501097A (ja) | 2005-01-13 |
Family
ID=23214285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003520705A Withdrawn JP2005501097A (ja) | 2001-08-16 | 2001-10-22 | 膨張可能な胃内滞留装置 |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1416914A1 (fr) |
JP (1) | JP2005501097A (fr) |
KR (1) | KR20040032918A (fr) |
CN (1) | CN1543337A (fr) |
BR (1) | BR0117123A (fr) |
CA (1) | CA2456976A1 (fr) |
CO (1) | CO5670360A2 (fr) |
IL (1) | IL160363A0 (fr) |
MX (1) | MXPA04001388A (fr) |
NO (1) | NO20040611L (fr) |
NZ (1) | NZ531461A (fr) |
PL (1) | PL368327A1 (fr) |
WO (1) | WO2003015745A1 (fr) |
ZA (1) | ZA200402066B (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005510531A (ja) * | 2001-11-21 | 2005-04-21 | イー−ゼット−イーエム,インク. | 医学的処置および診断的処置において使用される配合物 |
JP2009543886A (ja) * | 2006-07-19 | 2009-12-10 | スミスクライン・ビーチャム・コーポレイション | ガンマシンチグラフィー評価のために処方物を放射性標識する方法 |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2004308419B2 (en) * | 2003-12-24 | 2011-06-02 | Victory Pharma, Inc. | Enhanced absorption of modified release dosage forms |
US7699863B2 (en) | 2005-03-01 | 2010-04-20 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
US7785291B2 (en) | 2005-03-01 | 2010-08-31 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
CN102552103B (zh) * | 2010-12-20 | 2013-11-20 | 西安力邦医药科技有限责任公司 | 拉米夫定固体分散体、其制备方法、药物组合物和用途 |
WO2013183058A2 (fr) | 2012-06-07 | 2013-12-12 | Tulip Medical Ltd. | Dispositif étendu |
ES2926480T3 (es) | 2013-12-05 | 2022-10-26 | Epitomee Medical Ltd | Dispositivos y sistemas retentivos para la liberación in situ de principios activos farmacéuticos |
US20170266112A1 (en) | 2014-06-11 | 2017-09-21 | Massachusetts Institute Of Technology | Residence structures and related methods |
AU2015274456B2 (en) | 2014-06-11 | 2020-03-26 | Massachusetts Institute Of Technology | Self-assembled residence devices and related methods |
JP2018515476A (ja) | 2015-05-01 | 2018-06-14 | マサチューセッツ インスティテュート オブ テクノロジー | 誘発性形状記憶誘導デバイス |
CA3002916A1 (fr) | 2015-10-23 | 2017-04-27 | Lyndra, Inc. | Systemes a demeure gastriques pour liberation prolongee d'agents therapeutiques et leurs procedes d'utilisation |
SG11201804384UA (en) | 2015-12-08 | 2018-06-28 | Lyndra Inc | Geometric configurations for gastric residence systems |
AU2017336154B2 (en) | 2016-09-30 | 2023-11-09 | Lyndra Therapeutics, Inc. | Gastric residence systems for sustained delivery of adamantane-class drugs |
WO2019126218A1 (fr) * | 2017-12-18 | 2019-06-27 | Tris Pharma, Inc. | Composition de poudre de médicament à libération modifiée comprenant des systèmes de formation de raft de rétention gastrique ayant une libération de médicament par impulsions de déclenchement |
TR201914116A2 (tr) * | 2019-09-17 | 2021-04-21 | Univ Yeditepe | Doğal bi̇yomateryaller i̇le kri̇yojelleri̇n üreti̇m yöntemi̇ ve bu kri̇yojelleri̇n yumuşak doku i̇skelesi̇ veya i̇laç taşiyici si̇stem olarak kullanimi |
WO2022195476A1 (fr) | 2021-03-15 | 2022-09-22 | Clexio Biosciences Ltd. | Dispositifs de rétention gastrique pour l'évaluation d'états intragastriques |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4764380A (en) * | 1982-03-22 | 1988-08-16 | Alza Corporation | Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills |
US5232704A (en) * | 1990-12-19 | 1993-08-03 | G. D. Searle & Co. | Sustained release, bilayer buoyant dosage form |
DE4406424A1 (de) * | 1994-02-28 | 1995-08-31 | Bayer Ag | Expandierbare Arzneiformen |
PT1003476E (pt) * | 1997-08-11 | 2005-05-31 | Alza Corp | Forma de dosagem de agente activo de libertacao prolongada adaptada para retencao gastrica |
CZ2001901A3 (cs) * | 1998-09-14 | 2001-08-15 | Ranbaxy Laboratories Limited | Farmaceutická kompozice představující systém řízeného dodávání léku pro orální podání, poskytující časovou a místní kontrolu |
JP2000256216A (ja) * | 1999-03-04 | 2000-09-19 | Meiji Milk Prod Co Ltd | ゲル組成物 |
EP1305021A4 (fr) * | 2000-06-23 | 2009-09-23 | Teva Pharma | Composition a expansion rapide pour retention gastrique et liberation regulee d'agents therapeutiques, et formes posologiques renfermant cette composition |
-
2001
- 2001-10-22 EP EP01995328A patent/EP1416914A1/fr not_active Withdrawn
- 2001-10-22 CA CA002456976A patent/CA2456976A1/fr not_active Abandoned
- 2001-10-22 IL IL16036301A patent/IL160363A0/xx unknown
- 2001-10-22 BR BR0117123-2A patent/BR0117123A/pt not_active IP Right Cessation
- 2001-10-22 KR KR10-2004-7002254A patent/KR20040032918A/ko not_active Application Discontinuation
- 2001-10-22 PL PL01368327A patent/PL368327A1/xx not_active Application Discontinuation
- 2001-10-22 JP JP2003520705A patent/JP2005501097A/ja not_active Withdrawn
- 2001-10-22 MX MXPA04001388A patent/MXPA04001388A/es not_active Application Discontinuation
- 2001-10-22 WO PCT/US2001/046146 patent/WO2003015745A1/fr active Application Filing
- 2001-10-22 NZ NZ531461A patent/NZ531461A/en unknown
- 2001-10-22 CN CNA018235441A patent/CN1543337A/zh active Pending
-
2004
- 2004-02-11 NO NO20040611A patent/NO20040611L/no not_active Application Discontinuation
- 2004-03-12 CO CO04023075A patent/CO5670360A2/es not_active Application Discontinuation
- 2004-03-15 ZA ZA200402066A patent/ZA200402066B/en unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005510531A (ja) * | 2001-11-21 | 2005-04-21 | イー−ゼット−イーエム,インク. | 医学的処置および診断的処置において使用される配合物 |
JP4820054B2 (ja) * | 2001-11-21 | 2011-11-24 | ブラッコ ディアグノスティックス,インク. | 医学的処置および診断的処置において使用される配合物 |
JP2009543886A (ja) * | 2006-07-19 | 2009-12-10 | スミスクライン・ビーチャム・コーポレイション | ガンマシンチグラフィー評価のために処方物を放射性標識する方法 |
Also Published As
Publication number | Publication date |
---|---|
BR0117123A (pt) | 2004-09-28 |
PL368327A1 (en) | 2005-03-21 |
NZ531461A (en) | 2008-03-28 |
CN1543337A (zh) | 2004-11-03 |
ZA200402066B (en) | 2005-05-09 |
CA2456976A1 (fr) | 2003-02-27 |
EP1416914A1 (fr) | 2004-05-12 |
NO20040611L (no) | 2004-04-16 |
CO5670360A2 (es) | 2006-08-31 |
MXPA04001388A (es) | 2004-05-27 |
KR20040032918A (ko) | 2004-04-17 |
WO2003015745A1 (fr) | 2003-02-27 |
IL160363A0 (en) | 2004-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20040219186A1 (en) | Expandable gastric retention device | |
Shaha et al. | An overview of a gastro-retentive floating drug delivery system | |
Streubel et al. | Drug delivery to the upper small intestine window using gastroretentive technologies | |
Reddy et al. | Floating dosage systems in drug delivery | |
Prajapati et al. | Raft forming system—An upcoming approach of gastroretentive drug delivery system | |
Gopalakrishnan et al. | Floating drug delivery systems: A Review | |
Kotreka et al. | Gastroretentive floating drug-delivery systems: a critical review | |
JP2005501097A (ja) | 膨張可能な胃内滞留装置 | |
JP2002533380A (ja) | 多孔性粒子を含む剤形 | |
Ishak | Buoyancy-generating agents for stomach-specific drug delivery: an overview with special emphasis on floating behavior | |
WO2007106957A1 (fr) | Formes galéniques flottantes multiples à libération contrôlée | |
Vasave | A REVIEW ON: FLOATING DRUG DELIVERY SYSTEM | |
Ahmed et al. | Bioavailability of riboflavin from a gastric retention formulation | |
WO2022200971A1 (fr) | Procédé de production de matrices compactes de rétention gastrique pour la libération contrôlée de substances actives et matrices compactes ainsi obtenues | |
Jaimini et al. | A review on formulation and evaluation of gastroretentive floating tablet of Nifedipin | |
Kandwal et al. | Floating drug delivery system: A novel approach | |
Janhavi et al. | A Comprehensive Review on Gastro-Retentive Floating Drug Delivery Systems | |
Chaudhary et al. | Recent Development in Floating Drug Delivery System: An Overview | |
Omidian et al. | Oral targeted drug delivery systems: gastric retention devices | |
Katakam et al. | Floating drug delivery systems: a review | |
Choudhary et al. | A Review: Gastro Retentive Drug Delivery System | |
Mujoriya et al. | A Overview on Study of Floating Drug Delivery Systems | |
AU2002225872A1 (en) | Expandable gastric retention device | |
Singh et al. | Gastroretentive Delivery | |
KHARAT et al. | Indian Journal of Novel Drug Delivery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20041007 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20050502 |
|
A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20081006 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20081006 |